D. Jeffrey Keyser serves as Executive at ENCYSIVE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, D. Jeffrey Keyser has executed 11 insider transactions totaling $150.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 24, 2024 involved exercising options for 3,832 shares valued at $12.0K.
D. Jeffrey Keyser currently holds 41,927 shares of ENCYSIVE PHARMACEUTICALS INC (ENCY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, D. Jeffrey Keyser has been a net buyer of ENCY stock. They have purchased $150.0K and sold $0 worth of shares.
D. Jeffrey Keyser's most recent insider trade was on Jul 24, 2024, when they sold 3,832 shares at $3.13 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 11, 2020 | LTRN | $150.0K | Purchase | 10,000 | $15.00 | Discretionary |
| Dec 17, 2015 | ZSPH | $1.1M | Disposition | 12,353 | $90.00 | Discretionary |
| Dec 17, 2015 | ZSPH | $19.5M | Tender | 216,169 | $90.00 | Discretionary |
| Dec 9, 2015 | ZSPH | $100.0K | Option Exercise | 9,154 | $10.92 | Discretionary |
| Jun 23, 2014 | ZSPH | $0 | Conversion | 21,191 | $N/A | Discretionary |
| Jun 23, 2014 | ZSPH | $0 | Conversion | 48,744 | $N/A | Discretionary |
| Apr 1, 2008 | ENCY | $257.2K | Tender | 109,467 | $2.35 | Discretionary |
| Dec 11, 2007 | ENCY | $0 | Award | 70,000 | $N/A | Discretionary |
| Dec 11, 2007 | ENCY | $0 | Award | 35,000 | $N/A | Discretionary |